BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29654723)

  • 1. Long-Term Outcome of Homograft Implants Related to Donor and Tissue Characteristics.
    Axelsson I; Malm T
    Ann Thorac Surg; 2018 Jul; 106(1):165-171. PubMed ID: 29654723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular outflow tract reconstructions with cryopreserved cardiac valve homografts. A single surgeon's 10-year experience.
    Hopkins RA; Reyes A; Imperato DA; Carpenter GA; Myers JL; Murphy KA
    Ann Surg; 1996 May; 223(5):544-53; discussion 553-4. PubMed ID: 8651745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of Standard and Bicuspidalized Cryopreserved Homografts for Primary Right Ventricular Outflow Tract Reconstruction.
    Perri G; Polito A; Gandolfo F; Albanese SB; Carotti A
    J Heart Valve Dis; 2015 Jan; 24(1):83-8. PubMed ID: 26182624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease.
    Tweddell JS; Pelech AN; Frommelt PC; Mussatto KA; Wyman JD; Fedderly RT; Berger S; Frommelt MA; Lewis DA; Friedberg DZ; Thomas JP; Sachdeva R; Litwin SB
    Circulation; 2000 Nov; 102(19 Suppl 3):III130-5. PubMed ID: 11082375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of pulmonary and aortic homografts for right ventricular outflow tract reconstruction.
    Bando K; Danielson GK; Schaff HV; Mair DD; Julsrud PR; Puga FJ
    J Thorac Cardiovasc Surg; 1995 Mar; 109(3):509-17; discussion 517-8. PubMed ID: 7877312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durability of pulmonary homografts for reconstruction of the right ventricular outflow tract: how relevant are donor-related factors?
    Dekens E; Van Damme E; Jashari R; Van Hoeck B; François K; Bové T
    Interact Cardiovasc Thorac Surg; 2019 Apr; 28(4):503-509. PubMed ID: 30476047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of valve fenestrations and structural changes in homografts on the long-term outcome in the recipient.
    Axelsson I; Malm T; Nilsson J
    Cell Tissue Bank; 2021 Sep; 22(3):399-408. PubMed ID: 33576920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term performance of pulmonary homografts after the Ross procedure: experience up to 25 years.
    Oeser C; Uyanik-Uenal K; Kocher A; Laufer G; Andreas M
    Eur J Cardiothorac Surg; 2019 May; 55(5):876-884. PubMed ID: 30476036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood group incompatibility and accelerated homograft fibrocalcifications.
    Christenson JT; Vala D; Sierra J; Beghetti M; Kalangos A
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):242-50. PubMed ID: 14752436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstruction of right ventricular outflow tract in neonates and infants using valved cryopreserved femoral vein homografts.
    Schiller O; Sinha P; Zurakowski D; Jonas RA
    J Thorac Cardiovasc Surg; 2014 Mar; 147(3):874-9. PubMed ID: 24342904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reoperative homograft right ventricular outflow tract reconstruction.
    Bielefeld MR; Bishop DA; Campbell DN; Mitchell MB; Grover FL; Clarke DR
    Ann Thorac Surg; 2001 Feb; 71(2):482-7; discussion 487-8. PubMed ID: 11235694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryopreserved homograft in the Ross procedure: outcomes and prognostic factors.
    Kalfa D; Feier H; Loundou A; Fraisse A; Macé L; Metras D; Kreitmann B
    J Heart Valve Dis; 2011 Sep; 20(5):571-81. PubMed ID: 22066363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of HLA matching and associated factors on aortic valve homograft function.
    Dignan R; O'Brien M; Hogan P; Passage J; Stephens F; Thornton A; Harrocks S
    J Heart Valve Dis; 2000 Jul; 9(4):504-11. PubMed ID: 10947042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right ventricular outflow tract reconstruction with an allograft conduit in patients after tetralogy of Fallot correction: long-term follow-up.
    van de Woestijne PC; Mokhles MM; de Jong PL; Witsenburg M; Takkenberg JJ; Bogers AJ
    Ann Thorac Surg; 2011 Jul; 92(1):161-6. PubMed ID: 21592455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of the Z-score in size-reduced bicuspid homografts.
    Urso S; Rega F; Gewillig M; Eyskens B; Heying R; Daenen W; Meyns B
    J Heart Valve Dis; 2012 Jul; 21(4):521-6. PubMed ID: 22953682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bovine jugular vein conduit: a ten-year bi-institutional experience.
    Fiore AC; Brown JW; Turrentine MW; Ruzmetov M; Huynh D; Hanley S; Rodefeld MD
    Ann Thorac Surg; 2011 Jul; 92(1):183-90; discussion 190-2. PubMed ID: 21549348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midterm results of size-reduced cryopreserved homografts for right ventricular outflow tract reconstruction.
    Yang JH; Jun TG; Sung K; Kim WS; Lee YT; Park PW
    Ann Thorac Surg; 2010 Jun; 89(6):1821-6. PubMed ID: 20494034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the survival of cryopreserved homografts. The second homograft performs as well as the first.
    Meyns B; Jashari R; Gewillig M; Mertens L; Komárek A; Lesaffre E; Budts W; Daenen W
    Eur J Cardiothorac Surg; 2005 Aug; 28(2):211-6; discussion 216. PubMed ID: 15953733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Femoral vein homograft for neoaortic reconstruction in the Norwood stage 1 operation: a follow-up study.
    Seery TJ; Sinha P; Zurakowski D; Jonas RA
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):550-6. PubMed ID: 23312981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The valve-in-valve operation for aortic homograft dysfunction: a better option.
    Khalpey Z; Borstlap W; Myers PO; Schmitto JD; McGurk S; Maloney A; Cohn LH
    Ann Thorac Surg; 2012 Sep; 94(3):731-5; discussion 735-6. PubMed ID: 22626756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.